The National Institute of Neurological Disorders and Stroke (NINDS) is offering this grant to establish a Clinical Coordinating Center (CCC) for its Network for Excellence in Neuroscience Clinical Trials (NEXT). This grant is for the purpose of developing and conducting multiple, scientifically sound, exploratory clinical trials, including Phase 2 studies and biomarker/outcome validation research, for neurological disorders affecting adult and/or pediatric populations. The NEXT network aims to provide a robust, standardized infrastructure to facilitate rapid protocol development and implementation. While not disease-specific, it will efficiently coordinate specialist investigators for various opportunities. This funding opportunity specifically seeks applications for the Clinical Coordinating Center within this broad clinical research network.
Opportunity ID: 343670
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | RFA-NS-22-029 |
| Funding Opportunity Title: | Clinical Coordinating Center for the Network of Excellence in Neuroscience Clinical Trials (NEXT – CCC) (U01 Clinical Trial Not Allowed) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Cooperative Agreement |
| Category of Funding Activity: | Health |
| Category Explanation: | – |
| Expected Number of Awards: | – |
| Assistance Listings: | 93.853 — Extramural Research Programs in the Neurosciences and Neurological Disorders |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Sep 20, 2022 |
| Last Updated Date: | Sep 20, 2022 |
| Original Closing Date for Applications: | Nov 21, 2022 |
| Current Closing Date for Applications: | Nov 21, 2022 |
| Archive Date: | Dec 27, 2022 |
| Estimated Total Program Funding: | – |
| Award Ceiling: | $1,750,000 |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Private institutions of higher education For profit organizations other than small businesses Independent school districts Public housing authorities/Indian housing authorities Small businesses Special district governments Others (see text field entitled “Additional Information on Eligibility” for clarification) City or township governments Native American tribal governments (Federally recognized) Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education State governments County governments Public and State controlled institutions of higher education Native American tribal organizations (other than Federally recognized tribal governments) |
| Additional Information on Eligibility: | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are not allowed. |
Additional Information
| Agency Name: | National Institutes of Health |
| Description: | Reissue RFA-NS-11-009: The purpose of this funding opportunity announcement (FOA), issued by NINDS, is to invite applications to participate as a Clinical Coordinating Center in the Network for Excellence in Neuroscience Clinical Trials. This clinical research network will develop and conduct multiple, scientifically sound, possibly biomarker-informed exploratory clinical trials evaluating the most promising therapies, whether from academic, foundation or industry discoveries. Examples include Phase 2 clinical trials and clinical research studies aimed at validating biomarkers and clinical outcomes in preparation for clinical trials. The network will provide a robust, standardized, and accessible infrastructure to facilitate rapid development and implementation of protocols in neurological disorders affecting adult and/or pediatric populations. While the network will not be specific to one disease, it will have the capacity to coordinate a cadre of specialist investigators to implement studies efficiently in response to disease-specific opportunities. This FOA solicits applications for the Clinical Coordinating Center (CCC). Separate FOAs solicit applications for the Clinical Sites and the Data Coordinating Center. |
| Link to Additional Information: | https://grants.nih.gov/grants/guide/rfa-files/RFA-NS-22-029.html |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH Grants Information
grantsinfo@nih.gov Email:grantsinfo@nih.gov |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
Related Documents
Folder 343670 Full Announcement-RFA-NS-22-029 -> RFA-NS-22-029-Full-Announcement.pdf
Packages
| Agency Contact Information: | NIH Grants Information grantsinfo@nih.gov Email: grantsinfo@nih.gov |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| FORMS-G | Use for due dates on or after January 25, 2022 | PKG00276912 | Oct 21, 2022 | Nov 21, 2022 | View | |
| FORMS-H | Use for due dates on or after January 25, 2023 | PKG00277988 | Nov 04, 2022 | Nov 21, 2022 | View |
Package 1
Mandatory forms
343670 RR_SF424_5_0-5.0.pdf
343670 PHS398_CoverPageSupplement_5_0-5.0.pdf
343670 RR_OtherProjectInfo_1_4-1.4.pdf
343670 PerformanceSite_4_0-4.0.pdf
343670 RR_KeyPersonExpanded_4_0-4.0.pdf
343670 PHS398_ResearchPlan_4_0-4.0.pdf
343670 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf
Optional forms
343670 RR_Budget_3_0-3.0.pdf
343670 RR_SubawardBudget30_3_0-3.0.pdf
343670 PHS398_ModularBudget_1_2-1.2.pdf
343670 PHS_AssignmentRequestForm_3_0-3.0.pdf
Package 2
Mandatory forms
343670 RR_SF424_5_0-5.0.pdf
343670 PHS398_CoverPageSupplement_5_0-5.0.pdf
343670 RR_OtherProjectInfo_1_4-1.4.pdf
343670 PerformanceSite_4_0-4.0.pdf
343670 RR_KeyPersonExpanded_4_0-4.0.pdf
343670 PHS398_ResearchPlan_5_0-5.0.pdf
343670 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf
Optional forms
343670 RR_Budget_3_0-3.0.pdf
343670 RR_SubawardBudget30_3_0-3.0.pdf
343670 PHS398_ModularBudget_1_2-1.2.pdf
343670 PHS_AssignmentRequestForm_3_0-3.0.pdf
Share This Post, Choose Your Platform!
About the Author: osnqt
